Historical data
UPN . | Sex . | Age at study entry (y, m) . | Prior cytokine therapy . | Severe neutropenia . | Known neutrophil dysfunction . | IV antibiotic therapy . |
---|---|---|---|---|---|---|
21 | F | 5y 8m | yes | yes | yes | yes |
22 | M | 8m | yes | N/A | yes | no |
23 | M | 23y 10m | no | yes | yes | yes |
24 | F | 9y 2m | no | yes | no | yes |
25 | F | 8y 2m | yes | yes | yes | yes |
26 | F | 8m | no | yes | no | yes |
27 | F | 5y 0m | yes | yes | no | yes |
28 | F | 10y 8m | yes | yes | no | yes |
31 | F | 16y 1m | yes | yes | yes | yes |
32 | F | 9y 10m | no | yes | yes | yes |
33 | F | 6y 7m | no | yes | no | yes |
34 | F | 20y 11m | no | yes | no | no |
35 | M | 13y 1m | no | yes | no | yes |
UPN . | Sex . | Age at study entry (y, m) . | Prior cytokine therapy . | Severe neutropenia . | Known neutrophil dysfunction . | IV antibiotic therapy . |
---|---|---|---|---|---|---|
21 | F | 5y 8m | yes | yes | yes | yes |
22 | M | 8m | yes | N/A | yes | no |
23 | M | 23y 10m | no | yes | yes | yes |
24 | F | 9y 2m | no | yes | no | yes |
25 | F | 8y 2m | yes | yes | yes | yes |
26 | F | 8m | no | yes | no | yes |
27 | F | 5y 0m | yes | yes | no | yes |
28 | F | 10y 8m | yes | yes | no | yes |
31 | F | 16y 1m | yes | yes | yes | yes |
32 | F | 9y 10m | no | yes | yes | yes |
33 | F | 6y 7m | no | yes | no | yes |
34 | F | 20y 11m | no | yes | no | no |
35 | M | 13y 1m | no | yes | no | yes |
Historical data were obtained by review of patients' medical records. Prior cytokine therapy indicates any cytokine therapy given at any time prior to study enrollment. Severe neutropenia indicates ANC < 0.5 × 109 cells/L on 3 separate occasions at least one month prior to initiation of cytokine therapy. Known neutrophil dysfunction indicates that the patient had at least one abnormality in neutrophil function which was documented by laboratory assessment prior to study enrollment. IV antibiotic therapy indicates any hospital admission for IV antibiotic therapy for proven or suspected infection within the 12 months prior to initiation of any cytokine therapy. N/A indicates not available.